Role of HMGB1/TLR4 and IL-1β/IL-1R1 Signaling Pathways in Epilepsy

Shaohui Zhang; Feng Chen; Feng Zhai; Shuli Liang

doi:10.3389/fneur.2022.904225

Role of HMGB1/TLR4 and IL-1β/IL-1R1 Signaling Pathways in Epilepsy

Front Neurol. 2022 Jun 28:13:904225. doi: 10.3389/fneur.2022.904225. eCollection 2022.

Authors

Shaohui Zhang^{1

2}, Feng Chen¹, Feng Zhai¹, Shuli Liang³

Affiliations

¹ Functional Neurosurgery Department, National Children's Health Center of China, Beijing Children's Hospital, Capital Medical University, Beijing, China.
² Neurosurgery Department, People's Liberation of Army (PLA) General Hospital, Beijing, China.
³ Beijing Key Laboratory of Major Diseases in Children, Ministry of Education, Functional Neurosurgery Department, National Children's Health Center of China, Beijing Children's Hospital, Capital Medical University, Beijing, China.

Abstract

Epilepsy is a chronic disorder of the nervous system characterized by recurrent seizures. Inflammation is one of the six major causes of epilepsy, and its role in the pathogenesis of epilepsy is gaining increasing attention. Two signaling pathways, the high mobility group box-1 (HMGB1)/toll-like receptor 4 (TLR4) and interleukin-1β (IL-1β)/interleukin-1 receptor 1 (IL-1R1) pathways, have become the focus of research in recent years. These two signaling pathways have potential as biomarkers in the prediction, prognosis, and targeted therapy of epilepsy. This review focuses on the association between epilepsy and the neuroinflammatory responses mediated by these two signaling pathways. We hope to contribute further in-depth studies on the role of HMGB1/TLR4 and IL-1β/IL-1R1 signaling in epileptogenesis and provide insights into the development of specific agents targeting these two pathways.

Keywords: epilepsy; high mobility group box1; interleukin-1receptor1; interleukin-1β; toll-like receptor.

Publication types

Review